Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Merck
Cantor Fitzgerald
McKesson
Healthtrust
Mallinckrodt

Generated: April 21, 2019

DrugPatentWatch Database Preview

TYSABRI Drug Profile

« Back to Dashboard

Summary for Tradename: TYSABRI
Pharmacology for TYSABRI
Mechanism of ActionIntegrin Receptor Antagonists

US Patents for TYSABRI

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Pathologica LLC (San Francisco, CA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Biogen MA Inc. (Cambridge, MA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial BIOGEN MA INC. (Cambridge, MA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial Population Bio, Inc. (New York, NY) The Universite Paris-Sud (FR) The Assistance Publique--Hopitaux de Paris (APHP) (FR) The Institut National de la Sante et de la Recherche Medicale (INSERM) (FR) PML Screening, LLC (Newport Beach, CA) ➤ Try a Free Trial RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Try a Free Trial CytomX Therapeutics, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for TYSABRI

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
122019000006 Germany ➤ Try a Free Trial PRODUCT NAME: TISAGENLECLEUCEL; REGISTRATION NO/DATE: EU/1/18/1297 20180823
27/2006 Austria ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB; REGISTRATION NO/DATE: EU/1/06/346/001 20060627
122006000043 Germany ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB; NAT. REGISTRATION NO/DATE: EU /1/06/346/001 20060627; FIRST REGISTRATION: EU EU/1/06/346/001 20060627
300240 Netherlands ➤ Try a Free Trial PRODUCT: NATALIZUMAB, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; FIRST REGISTRATION, DATE: EU/1/06/346/001, 20060627
2006/025 Ireland ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB (ALSO KNOWN AS TYSABRI); REGISTRATION NO/DATE: EU/1/06/346/001 20060627
SZ 27/2006 Austria ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB
CA 2006 00025 Denmark ➤ Try a Free Trial PRODUCT NAME: NATALIZUMAB
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
McKinsey
Queensland Health
Harvard Business School
Medtronic
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.